Affiliation:
1. Universidade Salvador, Brasil
2. A. C. Camargo Cancer Center, Brasil
Abstract
Abstract Breast cancer is a public health problem because it is the malignant neoplasm with the highest incidence in women worldwide. The hereditary form corresponds to about 5% to 10% of all cases and is directly related to the inheritance of genetic mutations. The main ones occur in the BRCA1 and BRCA2 tumor suppressor genes. The identification of these mutations is extremely important because of the high risk of breast cancer development in this population, allowing differentiated screening strategies and the adoption of risk reduction measures. However, reflections on the ethical aspects related to the indiscriminate use of genetic testing are important and necessary. The objective of this study was to evaluate the knowledge and opinion of physicians of an oncology reference center on the indication of genetic tests for susceptibility to breast cancer given the ethical dilemmas to which they are submitted in medical practice.
Subject
Philosophy,Medicine (miscellaneous),Health (social science)
Reference26 articles.
1. Hereditary predisposition to breast cancer and its relation to the BRCA1 and BRCA2 genes: literature review;Coelho AS;Rev Bras Anal Clín [Internet],2018
2. BRCA1/2 testing for genetic susceptibility to cancer after 25 years: a scoping review and a primer on ethical implications;Petrova D;Breast [Internet],2022
3. Social and ethical implications of BRCA testing;Surbone A;Ann Oncol [Internet],2011
4. Breast cancer screening in women at higher-than-average risk: Recommendations from the ACR;Monticciolo DL;J Am Coll Radiol [Internet],2018
5. Breast cancer risk assessment models and high-risk screening;Barke LD;Radiol Clin North Am,2017